Financhill
Back

Bausch Health Companies 10K Form

Sell
40

BHC
Bausch Health Companies

Last Price:
7.97
Seasonality Move:
18.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive BHC News And Ratings

See the #1 stock for the next 7 days that we like better than BHC

BHC Financial Statistics

Sales & Book Value

Annual Sales: $8.76B
Cash Flow: $334M
Price / Cash Flow: 2.98
Annual Sales: $-3.19
Price / Book: 0

Profitability

EPS (TTM): -0.48000
Net Income (TTM): $-178M
Gross Margin: $6.2B
Return on Equity: 0%
Return on Assets: -0.66%

Bausch Health Companies Earnings Forecast

Key Bausch Health Companies Financial Ratios

  • The Gross Profit Margin over the past 31 years for BHC is 70.78%.
  • The Selling, General & Administrative Expenses for BHC have been equal to 33.31% of Gross Profit Margin.
  • The Research & Development expenses have been 6.90% of Revenue.
  • The Interest Expense is -224.32% of Operating Income.
  • The Net Earning history of BHC is -6.76% of Total Revenues.
  • Per Share Earnings over the last 31 years have been positive in 15 years.

Bausch Health Companies Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BHC
CUSIP: 071734
Website: bauschhealth.com

Debt

Debt-to-Equity Ratio: -18.32
Current Ratio: 1.19
Quick Ratio: 0.62

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 1.91

BHC Technical Analysis vs Fundamental Analysis

Sell
40
Bausch Health Companies (BHC) is a Sell

Is Bausch Health Companies a Buy or a Sell?